457 related articles for article (PubMed ID: 7860760)
1. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
Watson AD; Berliner JA; Hama SY; La Du BN; Faull KF; Fogelman AM; Navab M
J Clin Invest; 1995 Dec; 96(6):2882-91. PubMed ID: 8675659
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
Van Lenten BJ; Hama SY; de Beer FC; Stafforini DM; McIntyre TM; Prescott SM; La Du BN; Fogelman AM; Navab M
J Clin Invest; 1995 Dec; 96(6):2758-67. PubMed ID: 8675645
[TBL] [Abstract][Full Text] [Related]
4. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
[TBL] [Abstract][Full Text] [Related]
5. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
[TBL] [Abstract][Full Text] [Related]
6. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
7. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.
Vasques E; Almeida AL; Noya V; D'Alegria B; Marathe G; McIntyre TM; Tibiriçá E; Bozza PT; Silva AR; Castro-Faria-Neto HC
Endothelium; 2006; 13(1):1-8. PubMed ID: 16885061
[TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
Steinbrecher UP; Pritchard PH
J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
[TBL] [Abstract][Full Text] [Related]
9. A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells.
Navab M; Hama SY; Van Lenten BJ; Drinkwater DC; Laks H; Fogelman AM
J Clin Invest; 1993 Mar; 91(3):1225-30. PubMed ID: 8450051
[TBL] [Abstract][Full Text] [Related]
10. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
[TBL] [Abstract][Full Text] [Related]
11. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2003 Feb; 278(6):3937-47. PubMed ID: 12466264
[TBL] [Abstract][Full Text] [Related]
14. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K
Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
Tselepis AD; John Chapman M
Atheroscler Suppl; 2002 Dec; 3(4):57-68. PubMed ID: 12573364
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
[TBL] [Abstract][Full Text] [Related]
19. Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.
Zhang B; Fan P; Shimoji E; Itabe H; Miura S; Uehara Y; Matsunaga A; Saku K
Atherosclerosis; 2006 Jun; 186(2):291-301. PubMed ID: 16154574
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]